85%Confidence
0Views
FDASource
2026-04-17Date
Summary
Redness relief eye drops from K.C. Pharmaceuticals distributed through industrial and pharmacy channels show sterility issues, indicating quality control failures across their entire manufacturing operation. This affects specialized distribution channels including Cintas and AmerisourceBergen.
Actionable: Notify all business customers including Cintas and AmerisourceBergen about potential sterility risks in affected products.
AI Confidence: 85%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles; a) Industrial Eye Relief, Distributed by:
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now